Updates on Quantitative MRI of Diffuse Liver Disease: A Narrative Review

Biomed Res Int. 2022 Dec 28:2022:1147111. doi: 10.1155/2022/1147111. eCollection 2022.

Abstract

Diffuse liver diseases are highly prevalent conditions around the world, including pathological liver changes that occur when hepatocytes are damaged and liver function declines, often leading to a chronic condition. In the last years, Magnetic Resonance Imaging (MRI) is reaching an important role in the study of diffuse liver diseases moving from qualitative to quantitative assessment of liver parenchyma. In fact, this can allow noninvasive accurate and standardized assessment of diffuse liver diseases and can represent a concrete alternative to biopsy which represents the current reference standard. MRI approach already tested for other pathologies include diffusion-weighted imaging (DWI) and radiomics, able to quantify different aspects of diffuse liver disease. New emerging MRI quantitative methods include MR elastography (MRE) for the quantification of the hepatic stiffness in cirrhotic patients, dedicated gradient multiecho sequences for the assessment of hepatic fat storage, and iron overload. Thus, the aim of this review is to give an overview of the technical principles and clinical application of new quantitative MRI techniques for the evaluation of diffuse liver disease.

Publication types

  • Review

MeSH terms

  • Diffusion Magnetic Resonance Imaging
  • Elasticity Imaging Techniques* / methods
  • Hepatocytes / pathology
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Cirrhosis / diagnostic imaging
  • Liver Cirrhosis / pathology
  • Liver Diseases* / diagnostic imaging
  • Liver Diseases* / pathology
  • Magnetic Resonance Imaging / methods